← Back
$ATNF All transactions

180 Life Sciences Corp.

A

$ Value

$0

Shares

957,002

Price

$0

Filed

Aug 12

Insider

Name

Rudisill McAndrew

Title

CIK

0001511937

Roles

Director Other

Transaction Details

Transaction Date

2025-08-08

Code

A

Table

Derivative

Ownership

Indirect

Equity Swap

No

Shares After

957,002

Footnotes

The Reporting Person is the managing partner of BER I LLC ("BER"), and therefore may be deemed to beneficially own the securities held by BER. Mr. Rudisill disclaims beneficial ownership of the shares of common stock owned directly by BER, except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. | The Reporting Person is the managing partner of GER I LLC ("GER"), and therefore may be deemed to beneficially own the securities held by GER. Mr. Rudisill disclaims beneficial ownership of the shares of common stock owned directly by GER, except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. | The Reporting Person is the managing partner of MRR I LLC ("MRR"), and therefore may be deemed to beneficially own the securities held by MRR. Mr. Rudisill disclaims beneficial ownership of the shares of common stock owned directly by MRR, except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. | The Reporting Person is the managing partner and founder of Pelagic Capital Advisors LLC ("Pelagic"), and therefore may be deemed to beneficially own the securities held by Pelagic. Mr. Rudisill disclaims beneficial ownership of the shares of common stock owned directly by Pelagic, except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. | These warrants are currently exercisable, subject to a blocker provision that prevents PCAO (defined below) from exercising the warrants if it would be more than a 4.99% beneficial owner of the outstanding shares of the Issuer's common stock following such exercise, which percentage may be increased to up to 19.99% with at least 61 days prior written notice to the Issuer. | The warrants have no expiration date. | Issued in consideration for advisory and consulting services agreed to be rendered by PCAO. | The Reporting Person is the managing partner of PCAO LLC ("PCAO"), and therefore may be deemed to beneficially own the securities held by such entity. Mr. Rudisill disclaims beneficial ownership of the shares of securities owned directly by PCAO, except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

Filing Info

Accession No.

0001213900-25-075101

Form Type

4

Issuer CIK

0001690080

Rudisill McAndrew's History

Date Ticker Type Value
2026-04-02 FRMM A $0
2025-11-14 ETHZ G $0
2025-11-14 ETHZ G $0
2025-11-12 ETHZ A $0
2025-11-12 ETHZ F $0
2025-08-08 ATNF A $0

Other Insiders at ATNF (90d)

Insider Bought Sold Last
New Jason Griffin 2026-04-02
Rudisill McAndrew
Chief Executive Officer
2026-04-02
Smith Ryan Lewis 2026-04-02
Dalton Angela 2026-04-02
SUCKLING ANDREW P 2026-04-02
Heter Crystal Jane 2026-04-02
Saunders John Tazewell
Chief Financial Officer
2026-04-02
Edwards Michael A 2026-04-02